Ms. Tamara Mills is Managing Director of ImpactXHealth, an organization supporting the growth and development of the Australasian health innovation ecosystem through both accelerating company growth and facilitating strategic investments into early stage start-ups through to small cap publicly listed companies involved in the development of breakthrough medical and healthcare technologies.

Tamara has founded, funded and led a number of companies at the intersection of healthcare and the creative industries, including Glucotek, De Motu Cordis, merging design and science to disrupt current state of care, and has a track record in both successful capital raising and driving asset growth. Tamara currently sits on the Expert Investment Advisory Committee of Uniseed advising on investment decisions in the emerging health technology space and actively manages the venture capital funds for Creative Enterprise Australia.

Tamara has extensive experience in the commercialization of innovative medical technologies across the United States, Japan, Brazil, Europe and Australia, having held executive level positions within Australia and internationally at both publicly listed and private companies. Tamara has a strong track record in portfolio asset management in commercial radiopharmaceutical space having previously managed the pipeline product portfolio for Jubilant life sciences.